2014 ACR/ARHP Annual Meeting Archives - Page 3 of 202

Abstract Number: 885

A 2-Week Single-Blind, Randomized, 3-Arm Proof of Concept Study of the Effects of Secukinumab (anti-IL17 mAb), Canakinumab (anti-IL-1 b mAb), or Corticosteroids on Initial Disease Activity Scores in Patients with PMR, Followed By an Open-Label Extension to Assess Safety and Effect Duration
Abstract Number: 776

A Candidate Gene Approach Identifies IL33 as a Novel Genetic Risk Factor for GCA
Abstract Number: 1878

A Combination of Celecoxib and Famciclovir Is Efficacious in the Treatment of Fibromyalgia: Results of a Phase IIa Randomized, Double-Blind, Placebo-Controlled Study
Abstract Number: 2580

A Comparison of Baseline Characteristics and Real-Life Effectiveness of Anti-TNF Therapy in Non-Radiographic Axial Spondyloarthritis Versus Ankylosing Spondylitis – a Single Center Cohort Study
Abstract Number: 673

A Comparison of Rheumatoid Arthritis and Systemic Lupus Erythematosus Trial Design: Ways to Improve Positive Trials in Systemic Lupus Erythematosus
Abstract Number: 1374

A Comparison of the Risk for Cardiovascular Event in Patients with Rheumatoid Arthritis Treated with Biologic Disease Modifiers and Patients Treated with Methotrexate Only
Abstract Number: L2

A Comparison of Three Treatment Strategies in Recent Onset DMARD Naïve Juvenile Idiopathic Arthritis: 3-Months Results of the BeSt for Kids-Study
Abstract Number: 912

A Consensus Hybrid Definition Using a Conjoint Analysis Is the Proposed As Response Criteria for Minimal and Moderate Improvement for Adult Polymyositis and Dermatomyositis Clincal Trials
Abstract Number: 299

A Controlled Trial of Intra-Articular Corticosteroids with or without Methotrexate in Oligoarticular Juvenile Idiopathic Arthritis
Abstract Number: 2065

A Cross-Sectional Analysis of Psychological Symptoms, Sleep Quality, and Functional Balance in Fibromyalgia
Abstract Number: 1299

A Cross-Sectional Study of Mental Health Symptoms and Mental Health Care in Pediatric SLE/MCTD Patients and Their Peers
Abstract Number: 145

A Cut-Off Value Analysis By Ultrasound for the Diagnosis of Giant Cell Arteritis (GCA)
Abstract Number: 1349

A Decision Support Tool to Improve Herpes Zoster Vaccination Rates Among Patients Starting Biologic Medications
Abstract Number: 1167

A Description and Comparison of Treatments for Low Back Pain in the United States
Abstract Number: 526

A Descriptive and Comparative Study of the Transcriptome from Salivary Exosomes of Sjögren’s Syndrome Patients Using RNA-Seq
Abstract Number: 909

A Diagnostic Protocol for Giant Cell Arteritis (GCA) Using Ultrasound Assessment
Abstract Number: 729

A Dilated Esophagus Is an Independent Risk Factor for Interstitial Lung Disease in SSc
Abstract Number: 2445

A Distinct Profile of Circulating Microparticles Is Associated with Disease Features in Rheumatoid Arthritis Patients and Impairs Endothelial Functionality in Vitro
Abstract Number: 1476

A Dose Response Relationship Between Shared Epitope and ACPA Level: But Not All SE Alleles Are Created Equal
Abstract Number: 1679

A Double Blind Randomized Control Trial of Oral Tadalafil in Interstitial Lung Disease of Scleroderma
Abstract Number: 1948

A Dual Role for IFN-γ in Development of Peripheral B Cells in Lupus-Prone MRL/Lpr Mice
Abstract Number: 415

a Dual-Center, Double Blind Randomized Study for a New Scientific Approach in Assessment of Tender Joints in Inflammatory Arthritis Using the Smart Joint Assessor Glove Device (Smart JAG Device)
Abstract Number: 1694

a Feasibility Study of Subjective and Objective Assessment of Sublingual Abnormalities in Systemic Sclerosis
Abstract Number: 618

A Gender Bias in Gut Microbiota of SKG Mice Colonized with a Limited Bacterial Consortium Associated with Severity of Spondyloarthritis and Ileitis Triggered By Beta-Glucan
Abstract Number: 78

a HPLC-SRM-MS Based Method for the Detection and Quantification of Methotrexate Used at Doses in Clinical Practice for Patients with Rheumatological Disease in Urine
Abstract Number: 2350

A Humanized Monoclonal Antibody Raised Against a Heat Shock Protein Epitope Suppresses Autoimmune Inflammatory Diseases By Skewing the Immune System Selectively Towards an Anti-Inflammatory Response
Abstract Number: 1316

A Hybrid Conjoint Analysis Model Is Proposed As the Definition of Minimal, Moderate and Major Clinical Improvement in Juvenile Dermatomyositis Clinical Trials
Abstract Number: 2942

A Longitudinal Population-Based Study 1994-2010 of Age, Period, and Cohort Effects in the Prevalence of Arthritis: The Effect of Improving Socioeconomic Status and Increasing Obesity over Time
Abstract Number: 345

A Low Salt Diet Ameliorates Clinical Manifestations in Collagen-Induced Arthritis
Abstract Number: 1074

A Meta-Analysis of the Risk of Venous Thromboembolism in Inflammatory Rheumatic Diseases
Abstract Number: 2261

A Meta-Anlaysis of Bisphosphonate and Parathyroid Hormone (PTH) Use in Osteoporosis
Abstract Number: 2896

a Multi-Center Double-Blind, Randomized, Controlled Trial (db-RCT) to Evaluate the Effectiveness and Safety of Co-Administered Traumeel^® (Tr14) and Zeel^® (Ze14) Intra‑articular (IA) Injections Versus IA Placebo in Patients with Moderate-to-Severe Pain Associated with OA of the Knee
Abstract Number: 1259

A Multi-Center Study for Validation of a New Assay for Anti-Melanoma Differentiation-Associated Gene 5 (MDA5) Autoantibody
Abstract Number: 933

A Multi-Center, Double-Blind, Randomized-Withdrawal Trial of Subcutaneous Golimumab in Pediatric Patients with Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy: Week 48 Results
Abstract Number: 2438

A Multi-Centre Survey of Tolerability Problems for Patients on Regular Methotrexate
Abstract Number: 1928

A Multicenter, Prospective Cohort Study Using Nailfold Videocapillaroscopy and Other Clinical Characteristics to Determine the Risk of Developing New Digital Ulcers in Patients with Systemic Sclerosis
Abstract Number: 928

A Multinational Study of the Epidemiology, Treatment and Outcome of Childhood Arthritis: Preliminary Data from 6,940 Patients
Abstract Number: 2443

A New Meta-Analysis on Safety of Ketoprofen Vs Ibuprofen and Diclofenac: Risk and Benefit of Nsaids Beyond Efficacy Meta-Analysis
Abstract Number: 1257

A New Multianalyte Assay for Detection of Dermatomyositis-Specific Autoantibodies Undetectable By Commercially Available Immunoassays
Abstract Number: 2077

A New Tender Point on the Plantar Arch in Primary Juvenile Fibromyalgia: A Potential Point to be Considered
Abstract Number: 2309

A Novel Approach to Assess Wait-Times to Rheumatologists
Abstract Number: 2691

A Novel CD123^–CD11c^– Dendritic Cell Subset Increased in Relation to Disease Activity in Patients with Systemic Lupus Erythematosus
Abstract Number: 1951

A Novel CD27^(-) Spleen Tyrosine Kinase (Syk) Bright Memory B-Cell Subset Is Expanded in SLE
Abstract Number: 1132

A Novel Epigenetic Mark, Histone H1 Fucosylation, Orchestrates Macrophage Differentiation and Plasticity By Remodeling the Enhancer Landscape in Rheumatoid Arthritis
Abstract Number: 1886

A Novel Monocyte-Specific Transcript Underlies the Chromosome 21q22 Intergenic Genetic Association in Ankylosing Spondylitis
Abstract Number: 2796

A Novel Mouse Model of Osteochondromagenesis By Deleting NFATc1 in Mesenchymal Progenitors and Postnatal Chondrocytes
Abstract Number: 1940

A Novel Murine Model of B Cell-Mediated Glomerular Injury Is Mediated By Cytokines
Abstract Number: 1630

A Novel NMR Biomarker of Inflammation (GlycA) Is Elevated in Systemic Lupus Erythematosus
Abstract Number: 1830

A Novel Population Care Model in Rheumatoid Arthritis – Significant Improvement in Quality and Reduction in Cost of Care
Abstract Number: 674

A Novel Strategy to Identify and Evaluate Approved Drugs and Treatments for Repositioning As Therapies for Systemic Lupus Erythematosus (SLE)
Abstract Number: 329

A Novel, Small Molecule Cyclin-Dependent Kinase 4/6 Inhibitor As the New Option for Treatment of Rheumatoid Arthritis
Abstract Number: 856

A Pathogenic Role for the Gut Microbiota in Murine Antiphospholipid Syndrome and Lupus
Abstract Number: 1158

A Patient Survey Study of Zoledronic Acid Utilization and Factors Associated with Persistence
Abstract Number: 640

A Peptide Mimic Inhibits the Cross Reaction of Anti-DNA Antibodies with Glomerular Antigens
Abstract Number: 2295

A Pharmacometric Based Analysis of the Occurrence of Selected Safety Events of Special Interest and Canakinumab Exposure in Systemic Juvenile Idiopathic Arthritis Patients
Abstract Number: 1487

A Phase 1 Dose-Ranging Repeated-Dose Trial of Parenteral Staphylococcal Protein A (PRTX-100) in Patients with Active Rheumatoid Arthritis on Methotrexate or Leflunamide Therapy
Abstract Number: 1493

A Phase 1 Study of FPA008, an Anti-Colony Stimulating Factor 1 Receptor (anti-CSF1R) Antibody in Healthy Volunteers and Subjects with Rheumatoid Arthritis (RA): Preliminary Results
Abstract Number: 2233

A PHASE 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy Study of Apremilast (CC-10004) in Subjects with Erosive Hand Osteoarthritis
Abstract Number: 2835

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Study to Evaluate the Efficacy and Safety of Sirukumab in Patients with Active Lupus Nephritis
Abstract Number: L6

A PHASE 2, Randomized, Double-Blind Comparison of the Efficacy and Safety of PF-04171327 (1, 5, 10, 15 mg QD) Vs 5 and 10 Mg Prednisone QD or Placebo in Subjects with Rheumatoid Arthritis (RA) over 8 Weeks Followed By a 4-Week Taper of Study Drug
Abstract Number: 2826

A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Not on Concomitant Methotrexate
Abstract Number: 948

A Phase 2b, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Dose-Finding, Multi-Center Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate
Abstract Number: 249

A Phase 3 Open-Label Trial of Low-Dose Solumatrix Diclofenac in Patients with Osteoarthritis Pain: Impact of Long-Term Administration on Patient-Reported Outcomes
Abstract Number: 602

A Phase 3, Randomized, Controlled Trial of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Treatment of Psoriatic Arthritis: Long-Term (52-Week) Improvements in Physical Function
Abstract Number: 1502

A Phase I Trial Comparing PF-05280586 (A Potential Biosimilar) and Rituximab in Subjects with Active Rheumatoid Arthritis
Abstract Number: 952

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Multicenter Study to Evaluate the Efficacy and Safety of Clazakizumab, an Anti-IL-6 Monoclonal Antibody, in Adults with Active Psoriatic Arthritis
Abstract Number: 2828

A Physically Demanding Job May Amplify the Effect of Disease Activity on the Development of Syndesmophytes in Patients with Ankylosing Spondylitis
Abstract Number: 2377

A Pilot Randomized Controlled Trial of a Tailored Smoking Cessation Intervention for Rheumatoid Arthritis Patients
Abstract Number: 1321

A Pilot Study to Evaluate the Feasibility of Conducting Juvenile Localized Scleroderma Comparative Effectiveness Treatment Studies
Abstract Number: 922

A Potential Role for TLR4 Activation in Osteoarthritis Associated Pain
Abstract Number: 914

A Predictive Model of Disease Outcome in Rituximab-Treated Myositis Patients Using Clinical Features, Autoantibodies, and Serum Biomarkers
Abstract Number: 2824

A Profile of the Efficacy of Sarilumab Plus Methotrexate in Rheumatoid Arthritis Patients: Results of a 52-Week, Phase 3, Randomized, Double-Blind, Placebo-Controlled, International Study
Abstract Number: L24

A Progressive Increase in T Follicular Helper Cells Marks the Transition from Benign to Symptomatic Autoimmunity
Abstract Number: 2078

A Proposed Simple 3-Variable Index for Identification of Fibromyalgia, Analogous to Classification Criteria for RA and SLE
Abstract Number: 1642

A Prospective Study of Vitamin D Effects on T Cells Phenotype in Patients with Systemic Lupus Erythematosus Treated with Different Regimens of Supplementation for Two Years
Abstract Number: 561

A Psychometric Analysis of Outcome Measures in Trials of Peripheral Spondyloarthritis
Abstract Number: 1981

A Qualitative Analysis of Methotrexate Injection Videos on Youtube
Abstract Number: 1343

A Quality Improvement Initiative to Improve Pneumococcal Vaccination Rates in Immunosuppressed Patients
Abstract Number: 1448

A Questionnaire Assessment of Knowledge about Methotrexate of Patients with Rheumatoid Arthritis
Abstract Number: 490

A Randomised Controlled Trial Evaluating the Effect of Humira upon Endothelial Function in ACPA Positive Rheumatoid Arthritis â€“ an Interim Analysis
Abstract Number: 1824

A Randomized Double-Blind Placebo-Controlled Trial of Vitamin D Supplementation in Juvenile-Onset Systemic Lupus Erythematosus: Improvement in Disease Activity and Fatigue Scores
Abstract Number: 2825

A Randomized, Double-Blind, Phase 3 Equivalence Trial Comparing the Etanercept Biosimilar, HD203, with Etanercept (Enbrel^®), in Combination with Methotrexate (MTX) in Patients with Rheumatoid Arthritis (RA)
Abstract Number: 2938

A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Subcutaneous Golimumab in Patients with Active Nonradiographic Axial Spondyloarthritis
Abstract Number: 1509

A Randomized, Double-Blind, Three-Arm, Parallel Group, Single-Dose Study to Compare the Pharmacokinetics, Safety, and Tolerability of Three Formulations of Infliximab (CT-P13, EU-sourced Infliximab and US-sourced Infliximab) in Healthy Volunteers
Abstract Number: 128

A Rapid 4- Joint Ultrasonographic Score to Daily Monitoring Disease Activity in Patients with Rheumatoid Arthritis: Validity and Sensitivity to Change
Abstract Number: 1077

A Real-World Characterization of US Patients with “Moderate-to-Severe” Systemic Lupus Erythematosus
Abstract Number: 1826

A Renal Activity Index May Predict Histological Activity in Lupus Nephritis in Children
Abstract Number: 1927

A Retrospective Look at the Recurrence of Digital Ulcers in Patients with Scleroderma after Discontinuation of Oral Treprostinil
Abstract Number: 9

A Risk-Stratified Perioperative Management Strategy for Antiphospholipid Antibody Positive Patients Undergoing Kidney Transplantation
Abstract Number: 1050

A Role for Purinergic Receptor Signalling in Basic Calcium Phosphate Crystal-Induced Inflammation
Abstract Number: 1621

A Shift Towards Trans-Signalling Explains Relatively Low CRP Despite an Active Interleukin-6 (IL-6)/IL-6-Receptor (IL-6R) System in SLE
Abstract Number: 2634

A Signal of Improvement in Lupus Disease Activity at 3 Months Predicts Further Valid Improvement at 6 Months
Abstract Number: 882

A Signature of microRNAs Overexpressed in Inflamed Temporal Arteries of Patients with Giant Cell Arteritis
Abstract Number: 1107

A Strong Association Between Memory Loss and Word Finding Difficulties in Fibromyalgia
Abstract Number: 505

A Structured Approach for Comparative Benefit-Risk Assessment of Rituximab for the Treatment of Rheumatoid Arthritis
Abstract Number: 577

A Substantial Decrease in Work Productivity and Physical Health-Related Quality of Life in Chronic Back Pain of Recent Onset: Data from the SPACE-Cohort
Abstract Number: 1358

A Systematic Analysis of the Safety of Prescribing Anti-Rheumatic Immunosuppressive and Biologic Drugs in Pregnant Women
Abstract Number: 1660

A Systematic Review and Network Meta-Analysis of Cyclophosphamide and Mycophenolate Mofetil in Lupus Nephritis
Abstract Number: 962

A Systematic Review and Network Meta-Analysis of the Risk of Serious Infections with Immunosuppressives for Lupus Nephritis
Abstract Number: 2325

A Systematic Review of the Educational Approach of Occupational Therapy for Rheumatoid Arthritis
Abstract Number: 851

A Tailored Approach to Reduce Dose of Anti-TNF Drugs Is Equally Effective, but Substantially Less Costly Than Standard Dosing in Patients with Ankylosing Spondylitis over One Year: A Propensity Score-Matched Cohort Study
Abstract Number: 2422

A Tailored Approach to Reduce Dose of TNF Inhibitors Is Equally Effective, but Substantially Less Costly Than Standard Dosing in Patients with Rheumatoid Arthritis over One and Two Years: A Prospective Cohort Study
Abstract Number: 2102

A Tissue-Specific Lincrna in the TRAF1-C5 Risk Locus As a Putative Cis-Regulator, Bridging Genetics and Disease
Abstract Number: 2034

A Treat-to-Target Strategy Preserves Work Capacity in Early Rheumatoid Arthritis (RA)
Abstract Number: 937

A Unique Role for IL-18 Receptor-α in Monocyte Migration in RA and K/BxN Serum Transfer Arthritis
Abstract Number: 456

AAA-Atpase p97 Regulates Autophagy-Associated Cell Death in Arthritis
Abstract Number: 504

Abatacept after Rituximab in Rheumatoid Arthritis. a Pan-European Collaboration of RA Registries
Abstract Number: 472

Abatacept Can be Used Safely for RA Patients with Interstitial Lung Disease
Abstract Number: 1578

Abatacept Improves Synovitis As Assessed By Magnetic Resonance Imaging (MRI) in Psoriatic Arthritis – Preliminary Analysis from a Single Centre, Placebo-Controlled, Crossover Study
Abstract Number: 2934

Abatacept reduces Circulating Effector Memory T-Helper Cells in Patients with Primary Sjögren’s Syndrome
Abstract Number: 2151

Abatacept Related Infections: No Association with Gammaglobulin Reduction
Abstract Number: 411

ABCB1 and ABCG2 Drug-Efflux Transporters Function and Its Association with Disease Activity in a Cohort of Patients with Rheumatoid Arthritis
Abstract Number: 1769

Abdominal Visceral Adipose Tissue Measured By DXA As a Novel Surrogate Marker of Cardiovascular Risk in Primary Necrotizing Vasculitides
Abstract Number: 1592

Ability of Clinical Variables to Predict Radiographic Damage in Psoriatic Arthritis
Abstract Number: 741

Abnormal Right Ventricular Longitudinal Strain Detected in Systemic Sclerosis Patients Prior to Abnormalities in Conventional Measures of Right Ventricular Size and Function
Abstract Number: 1213

Absence of Hormone Responsive Estrogen Receptor Alpha Reduces the Activation of Plasmacytoid Dendritic Cells in Lupus Prone Mice
Abstract Number: 1030

ABT-122, a Novel Dual Variable Domain (DVD)-Ig^TM, Targeting TNF and IL-17, Inhibits Peripheral Blood Mononuclear Cell Production of GM-CSF and Decreases Lymphocyte Expression of CXCR4 in Healthy Subjects
Abstract Number: 858

ABT-199, a Potent and Selective BCL-2 Inhibitor, Prevents Lupus Nephritis in the Spontaneous NZB/W F1 Mouse Model By Depleting Selective Lymphocyte Populations While Sparing Platelets
Abstract Number: 1441

Accelerated Aging in DMARD and Treatment Naive Early Rheumatoid Arthritis Patients Measured By a Stem Cell Assay Is Associated with Increased LDL and Is Linked to Impaired Cardiopulmonary Function
Abstract Number: 1364

Accelerated Diastolic Dysfunction in Premenopausal Women with Rheumatoid Arthritis
Abstract Number: 883

Accuracy of High Resolution MRI of Scalp Arteries for the Diagnosis of Giant Cell Arteritis: Results of a Prospective Study
Abstract Number: 1303

Accuracy of Laboratory Measures and Clinical Renal Activity Indices for Reflecting Biopsy-Proven Lupus Nephritis (LN) Activity
Abstract Number: 2289

Accuracy of the Use of Administrative Diagnostic Codes to Identify Pediatric in-Patient Musculoskeletal Conditions in an African Tertiary Hospital
Abstract Number: 942

ACR/EULAR Remission in RA patients in Clinical Practice – Does Substitution of Patient Global with Pain Score Change Remission Rates? Data from the Danish Danbio Registry
Abstract Number: 2681

Activated SLE-T Cells Enhance the Interferon-Alpha Production By Plasmacytoid Dendritic Cells Stimulated By RNA-IC
Abstract Number: 2949

Activation of AMP-Activated Protein Kinase (AMPK) By Berberine Limits Both Surgical Knee Instability-Induced and Aging-Related Osteoarthritis in Mice
Abstract Number: 23

Activation of EPAC1/2 Is Essential for Osteoclast Formation By Modulating NFkB Nuclear Translocation and Actin Cytoskeleton Rearrangements
Abstract Number: 2100

Activation of NFkβ Pathways in Sjögren’s Syndrome Related Lymphomagenesis-Role of the His159Tyr Mutation of the BAFF-R Receptor
Abstract Number: 1195

Activation of the nlrp3 Inflammasome By an Endogenous TLR2 Ligand in Rheumatoid Arthritis
Abstract Number: 3006

Activation of the Thromboxane A2 Receptor By 8-Isoprostane Inhibits the Pro-Angiogenic Effect of Vascular Endothelial Growth Factor in Scleroderma
Abstract Number: 2348

Activatory Fc Gamma Receptor IV Plays a Crucial Role in Pathogenesis of Experimental Immune Complex Mediated Chronic Arthritis
Abstract Number: 855

Active and Structural Lesions on MRI of the Sacroiliac Joints Predict Major Clinical Responses in Patients with Non-Radiographic Axial Spondyloarthritis Treated with Etanercept
Abstract Number: 936

Active Invasion of Periodontal Bacteria into Synovial Joint Exacerbates Collagen-Induced Arthritis in Disease-Prone B10 Riii Mice
Abstract Number: 693

Acute Myocarditis in Patients with Systemic Lupus Erythematosus: Experience from Affiliated Hospitals of Catholic University of Korea
Abstract Number: 2203

Adalimumab Therapy Improves Insulin Sensitivity in Non-Diabetic Psoriatic Patients: A 6-Month Prospective Study
Abstract Number: 2509

ADAM-10 As a Tocilizumab Treatment Predictive Factor in Rheumatoid Arthritis
Abstract Number: 1028

ADAM-10 Plays Monocyte Migration and Adhesion in Rheumatoid Arthritis Synovial Fibroblasts
Abstract Number: 1629

Added Value of the Determination of Anti-Ribosomal and Anti-Ku Antibodies for Diagnosis of Systemic Lupus Erythematosus
Abstract Number: 2484

Adding an Initial Six-Month Course of Infliximab to an Active Combination Treatment Is Cost Saving in Working-Aged Early Rheumatoid Arthritis Patients
Abstract Number: 22

Adenosine a_2A Receptor (A2AR) Stimulation Inhibits Osteoclast Differentiation and Promotes Osteoblast Formation By Regulation of Axon Guidance Proteins
Abstract Number: 2947

Adenosine a_2A Receptor As a Potential New Therapeutic Target for the Prevention/Treatment of Osteoarthritis
Abstract Number: 1729

Adenosine A2A Receptor (A2AR) Promotes Collagen Type 3 Expression Via β-Catenin Activation
Abstract Number: 19

Adenosine Receptors Stimulate Bone Regeneration
Abstract Number: 2381

Adherence to a Treat-to-Target (T2T) Strategy in Early Rheumatoid Arthritis. Is It Feasible in Daily Clinical Practice?
Abstract Number: 2316

Adherence to Denosumab in a Large Healthcare System
Abstract Number: 2382

Adherence to Dmards in the First Six Months of Treatment in Early Arthritis Patients; Comparing Three Adherence Measures
Abstract Number: 181

Adherence to Treatment Recommendations of Gout: A Patient Survey in China
Abstract Number: 966

Adiponectin Is an Endogenous Anti-Fibrotic and Target in Systemic Sclerosis: Novel Link Between Fibrosis and Metabolism
Abstract Number: 532

Adipose Tissue Is Prominent in Salivary Glands of Sjögren’s Syndrome Patients and Appears to Influence the Autoimmune Microenvironment in These Organs
Abstract Number: 1305

Adiposity and Adipokines Are Associated with Insulin Resistance in Pediatric Systemic Lupus Erythematosus
Abstract Number: 478

Adverse Events and Infections in Patients with Rheumatoid Arthritis Treated with Conventional Drugs or Biologic Agents: A Real World Study
Abstract Number: 1828

Adverse Pregnancy Outcomes in Adolescents and Young Women with Systemic Lupus Erythematosus: A National Estimate
Abstract Number: 61

Advocating for Pediatric Rheumatology Care in the Mid-Canadian Provinces: Large Geographic Area, Large Pediatric Population, Low Number of Pediatric Rheumatologists and Allied Health Workers Identified As Unique Challenges
Abstract Number: 1859

Age-Specific Predictors of Mortality in SLE
Abstract Number: 1936

Ageism, Fear, and Competing Co-Morbidities – Why Older Patients May Not Seek Care for Restricting Back Pain: A Qualitative Study
Abstract Number: 2140

Agreement Among FDG-PET/CT, Ultrasound and Physical Examination in Patients with Inflammatory Arthritis
Abstract Number: 283

Agreement Between Enthesitis Evaluation By Manual Palpation and Dolorimetry in Juvenile Spondyloarthritis
Abstract Number: 2322

Aim for Better Gout Control: A Retrospective Analysis of Preventable Hospital Admissions for Gout
Abstract Number: 1199

Alarmins S100A8/S100A9 Aggravate Osteophyte Formation in Experimental Osteoarthritis and Predict Osteophyte Progression in EARLY Human Osteoarthritis in the Dutch Check Cohort
Abstract Number: 2442

Aligning Ethics with Digital Health Technologies and Shared Decision-Making: Interview Accounts of Patients and Clinicians
Abstract Number: 160

All Men with Gout Should be Screened for Erectile Dysfunction
Abstract Number: 960

Allogeneic Mesenchymal Stem Cell Transplantation for Lupus Nephritis Patients Refractory to Conventional Therapy
Abstract Number: 2185

Alterations in B Cell Complement Processing Related to a Lupus-Associated Variant in Complement Receptor 2
Abstract Number: 2695

Alterations in B Cell Subsets and BAFF Levels in Autoimmune Rheumatic Diseases Treated with B Cell Depletion Therapy: Rituximab
Abstract Number: 1737

Altered Phenotype and Function of Senescent Regulatory T Cells in Rheumatoid Arthritis
Abstract Number: 2845

Altered Plasticity of Inflammatory CD4 T Cells Contributing to Th17 Shift in Rheumatoid Arthritis
Abstract Number: 1498

ALX-0061, an Anti-IL-6R Nanobody^®foruse in Rheumatoid Arthritis, Demonstrates a Different in Vitro Profile As Compared to Tocilizumab
Abstract Number: 3003

Am80 Ameliorates Bleomycin-Induced Dermal Fibrosis By Suppressing the Pro-Fibrotic Phenotype of Fibroblasts, Endothelial Cells, and Immune Cells
Abstract Number: 3011

Ambulatory Gait Analysis in Clinical Practice: Single or Dual Task Conditions?
Abstract Number: 1986

Ambulatory Rheumatology Curriculum: Effect of Multimodal Curriculum Enhancement
Abstract Number: 2344

Amelioration of Collagen-Induced Arthritis By Water-Soluble Fullerene C60(OH)₃₆ Nanoparticles through the Inhibition of Angiogenesis
Abstract Number: 934

Amelioration of Inflammatory Arthritis By Anti-TNF Therapy Is Associated with Restoration of Lymphatic Contraction
Abstract Number: 857

Amelioration of Systemic Lupus Erythematosus (SLE) in NZM 2328 Mice By Selectively Blocking Engagement of Two BAFF Receptors
Abstract Number: 84

Amerindian Ancestry Influences Polyautoimmunity
Abstract Number: 2039

Among Persons Assayed with Lower Serum Interleukin-1 Beta (IL-1β) Levels, Serum Androstenedione (Δ4A) and Testosterone (T) Were Significantly Lower in a Community-Based Cohort of Rheumatoid Arthritis Multi-Years before Clinical Onset (Pre-RA) Than in Non-RA Matched Control (CN) Subjects
Abstract Number: 2888

Amount of Smoking, Duration of Smoking Cessation, and Their Interaction with Silica Exposure in the Risk of Rheumatoid Arthritis: Results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis Study
Abstract Number: 327

AMPK Activation in Inflammatory Arthritis
Abstract Number: 221

An Analysis of Age-Related Loss of Skeletal Muscle Mass and Its Significance on Osteoarthritis in a Korean Population
Abstract Number: 1514

An Analysis of in-Vitro Cytokine Inhibition Profiles of Tofacitinib and Other Janus Kinase Inhibitors at Clinically-Meaningful Concentrations
Abstract Number: 1757

An Analysis of the Incidence and Characteristics of ANCA Positive Vasculitis before and after the Christchurch Earthquake
Abstract Number: 2842

An Anti CD123 Monoclonal Antibody (CSL362) Depletes Plasmacytoid Dendritic Cells and Inhibits CpG Upregulated IFNα Production and IFNα-Inducible Gene Expression in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus
Abstract Number: 1703

An Association of Anti-PM/Scl Antibody Reactivity with Risk of Malignancy in Scleroderma
Abstract Number: 2630

An Evaluation of Quality of Life of Patients with Systemic Lupus Erythematosus Attending Rheumatology Clinic in Kenyatta National Hospital, Nairobi, Kenya
Abstract Number: 266

An Examination of the Interaction of Opioid Use, Pain, and Depression
Abstract Number: 2240

An Exploratory 4-Week Study of a P2X3 Antagonist AF-219 in the Treatment of Patients with Osteoarthritis (OA) of the Knee
Abstract Number: 930

An Exploratory Analysis of Predictors of Response from 12-Weeks of Canakinumab Therapy in Patients with Active Systemic Juvenile Idiopathic Arthritis
Abstract Number: 880

An Immunochip Study Confirms a Strong Contribution of HLA Class I and II Genes in the Susceptibility to Giant Cell Arteritis
Abstract Number: 1555

An Indirect Comparison and Cost per Responder Analysis of Adalimumab, Methotrexate (MTX) and Apremilast in the Treatment of MTX-naïve Psoriatic Arthritis (PsA) Patients
Abstract Number: 1680

an Indirect Comparisons Analysis of Medications Used for Treatment of Raynaud’s Phenomenon
Abstract Number: 240

An Observational Study on the Influence of Glucocorticoid Exposure on Bone
Abstract Number: 1253

Anakinra – a Promising New Therapy for Idiopathic Recurrent Pericarditis
Abstract Number: 1254

Anakinra for the Management of Resistant Idiopathic Recurrent Pericarditis in Adults
Abstract Number: 1103

Analgesic and Anti-Hyperalgesic Effects of Deep Dry Needling Therapy in Fibromyalgia Patients
Abstract Number: 1972

Analysis of Anakinra in Primary Human Cell Systems Reveals an in Vitro Signature for Skin-Related Side Effects
Abstract Number: 1416

Analysis of Cardiac Involvement in Patients with Amyloid a (AA) Amyloidosis Due to Rheumatoidarthritis
Abstract Number: 1264

Analysis of Clinical Manifestations and Myositis-Specific Autoantibodies Associated with Severity of Physical Dysfunction after Treatment for Polymyositis and Dermatomyositis
Abstract Number: 2489

Analysis of Early Neutropenia, Clinical Response, and Serious Infection Events in Patients Receiving Tofacitinib for Rheumatoid Arthritis
Abstract Number: 1759

Analysis of Employment, Work Disability and Quality of Life of Patients with ANCA-Associated Vasculitis
Abstract Number: 1517

Analysis of Gene Expression Fluctuation with Abatacept Highlights the Involvement of the Proteasome Pathway As a Mechanism of Action of Abatacept in Rheumatoid Arthritis
Abstract Number: 460

Analysis of Non-Melanoma Skin Cancer Across the Tofacitinib Rheumatoid Arthritis Clinical Program
Abstract Number: 1485

Analysis of Patient-Reported Outcomes during Treatment with Mavrilimumab, a Human Monoclonal Antibody Targeting GM-CSFRá, in the Randomized Phase 2b Earth Explorer 1 Study
Abstract Number: 464

Analysis of Pooled Data from Two Randomized Controlled Trials and Their Open-Label Extensions: Long-Term Safety in Rheumatoid Arthritis before and after Certolizumab Pegol Dose Increase/Decrease
Abstract Number: 1320

Analysis of Risk Factors for Thrombosis in Pediatric Patients with Systemic Lupus Erythematosus
Abstract Number: 513

Analysis of Shoulder Joint Destruction in Rheumatoid Arthritis Patients Treated with Biologics
Abstract Number: 2478

Analysis of the Clinical Sustained Response after Retreatment with a Lower Dose of Rituximab in Patients with Chronic Inflammatory Arthropathies
Abstract Number: 2063

Analysis of the Fibromyalgia Rapid Screening Tool Spanish Version to Detect Fibromyalgia in Primary Health Care Centers
Abstract Number: 615

Analysis of the Gut Transcriptome in HLA-B27 Transgenic Rats By RNA-Seq Reveals Prominent Interferon and IL-23/IL-17 Axis Signatures
Abstract Number: 237

Analysis of Vitamin D Receptor Gene Polymorphisms and Bone Mineral Density in a Population of Women with Rheumatoid Arthritis in Use of Steroid
Abstract Number: 2521

Analysis on Predictors for Long-Term Clinical Efficacies of Golimumab in Patients with Rheumatoid Arthritis
Abstract Number: 2436

Analytical and Clinical Evaluation of an Immunoassay for Estimating Immunogenicity of Infliximab and Etanercept in Indian Population
Abstract Number: 180

Analytical Comparison Between Point of Care Uric Acid Testing Meters
Abstract Number: 1029

Anandamide and Related Eicosanoids Decrease the Production of Pro-Inflammatory Cytokines in Synovial Fibroblasts By a COX-2 Dependent Mechanism: Involvement of Calcium and TRP Channels
Abstract Number: 2643

Angiogenic and Antiangiogenic Factors in Patients with Systemic Lupus Erythematosus
Abstract Number: 1376

Angiographic Pattern Among Rheumatoid Arthritis Patients Who Are Hospitalized Due to Acute Coronary Syndrome
Abstract Number: 38

Angiopoietin-like 4 Is over-Expressed in Rheumatoid Arthritis: A Potential Role in Pathological Bone Resorption
Abstract Number: 2604

Ankylosing Spondylitis and Non- Radiographic Axial Spondyloarthritis : the Same Syndrome or Different Diseases? Analysis from Esperanza Cohort
Abstract Number: 888

Annual Medical Care Expenditures Among US Adults with Gout, 2005 – 2011
Abstract Number: 980

Annual Medical Care Expenditures Among US Adults with Osteoarthritis, 2008 – 2011
Abstract Number: 1160

Annual Real-Practice Costs of Biologics for 200 Cases with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Treated By Tight Control and Treat to Target Strategy Permitting Dose Reduction
Abstract Number: 2464

Anti-Arthritic Effect of Tubastatin A, a Novel Histone Deacetylases-6 Inhibitor, Is Mediated By Stabilization of IkB Via Suppression of Ubiquitin-Proteasome Pathway
Abstract Number: 2392

Anti-Carbamylated Antibodies (anti-CarPA) Are Associated with Long Term Disability and Increased Disease Activity in Patients with Early Inflammatory Arthritis: Results from the Norfolk Arthritis Register (NOAR)
Abstract Number: 442

Anti-Carbamylated Protein Antibody Levels Are Elevated in Seropositive Rheumatoid Arthritis and Correlate with Anti-Sa/Citrullinated Vimentin Antibody Levels
Abstract Number: 437

Anti-Citrullinated Heat Shock Protein 90 Antibodies Identified in Bronchoalveolar Lavage Fluid Are a Marker of Lung-Specific Immune Responses
Abstract Number: 1377

Anti-Citrullinated Peptide Antibody Titers and the Prevalence of Interstitial Lung Disease in Patients with and without Rheumatoid Arthritis
Abstract Number: 993

Anti-Citrullinated Proteins Antibodies Promote Synovial Fibroblast Migration in Rheumatoid Arthritis
Abstract Number: 2797

Anti-Citrullinated Proteins Antibodies Promotes Osteoclastogenesis and Bone Destruction in Rheumatoid Arthritis
Abstract Number: 1638

Anti-Dense Fine Speckled 70 Antibodies: Long-Term Followup Study of Clinical Associations in a US Laboratory Patient Population
Abstract Number: 598

Anti-Drug Antibodies As a Predictor for the Discontinuation of Anti-TNF Agents in Patients with Spondyloarthrtis
Abstract Number: 3002

Anti-Fibrotic Effects of a Newly Discovered HGF Receptor Carboxy-Terminal Fragment in Systemic Sclerosis
Abstract Number: 769

Anti-Fibrotic Effects of an Investigational Drug: Bis-Oxetanyl Sulfoxide
Abstract Number: 2345

Anti-IL-6 Receptor Antibody Prevents Deterioration in Bone Structure in a Mouse Model of Collagen-Induced Arthritis
Abstract Number: 323

Anti-Inflammatory Marine Compound, Lyy-B2, Ameliorates Rheumatoid Arthritis through Inhibition of Osteoclast Differentiation
Abstract Number: 2457

Anti-Major Histocompatibility Complex Class I-Related Chain a (MICA) Antibodies in Rheumatoid Arthritis Patients with Interstitial Lung Disease
Abstract Number: 1037

Anti-MDA5 Antibody Associated Myositis Compared to DM Patient: A Distinct Muscular Pattern Associated with a shared IFN Signature
Abstract Number: 1266

Anti-MDA5 Is Associated with Rapidly-Progressive Interstitial Lung Disease and Poor Survival in U.S. Patients with Amyopathic and Myopathic Dermatomyositis
Abstract Number: 1835

Anti-Osteoporosis Medication Use after Hip or Vertebral Fracture
Abstract Number: 1317

Anti-p155/140 Autoantibodies and Selected Features at Illness Onset Are Associated with a Chronic Course of Illness in the Juvenile Idiopathic Inflammatory Myopathies
Abstract Number: 1474

Anti-Peptidyl Arginine Deiminase 4 Antibodies in African-Americans with Rheumatoid Arthritis and Radiographic Scores
Abstract Number: 398

Anti-Rheumatic Therapy Decreases Syndecan-1 Shedding in Rheumatoid Arthritis (RA)
Abstract Number: 2991

Anti-Ribosomal P Antibody Is a Key Autoantibody Associated with Complications of NP-SLE with High-Levels of CSF IL-8
Abstract Number: 1827

Anti-Ro and Anti-La Antibodies in the General Pregnant Population
Abstract Number: 2543

Anti-Ro/SSA Positive Incomplete Sjögren’s Syndrome
Abstract Number: 1209

Anti-Scavenger Receptor Autoantibodies Disrupted Marginal Zone Macrophage Integrity Via Bruton’s Tyrosine Kinase
Abstract Number: 2759

Anti-TNF Treatment for Refractory Vascular Involvement of Behçet’s Syndrome
Abstract Number: 1741

Anti-TNFα Treatment Increases IL-17A+ and IL-22+ T Cells in Spondyloarthritis Regardless of Concomittant Gut Inflammation
Abstract Number: 929

Antibiotic Exposure and the Development of Juvenile Idiopathic Arthritis: A Population-Based Case-Control Study
Abstract Number: 2019

Antibodies to Citrullinated Clusterin, Filaggrin, Vimentin, and Fibrinogen Are Associated with Blood Pressure in First-Degree Relatives of Rheumatoid Arthritis Patients: The Studies of the Etiology of Rheumatoid Arthritis
Abstract Number: 2539

Antibodies to Human Interferon-Inducible Protein-16 Are Present in Primary Sjögren’s Syndrome and Systemic Lupus, but Are Rare in Dermatomyositis
Abstract Number: 1620

Antibody to Malondialdehyde-Acetaldehyde Adducts (MAA) As a Potential Biomarker of Inflammation in Systemic Lupus Erythrematosus (SLE)
Abstract Number: 1743

Antigen-Specificity Regulates Peripheral Homeostasis of Regulatory T Cells
Abstract Number: 871

Antimalarials Regulate TLR7/8 Mediated Macrophage Activation Via Epigenetic Modification at the TNFα Promoter
Abstract Number: 1308

Antinucleosome Antibodies As Potential Diagnostic and Prognostic Biomarkers in Childhood Onset Systemic Lupus Erythematosus
Abstract Number: 10

Antiphospholipid Antibodies and Neuropsychiatric Events in Pediatric Patients
Abstract Number: 1702

Antiphospholipid Antibodies in Systemic Sclerosis: Prevalence and Clinical Significance?
Abstract Number: 2867

Antiphospholipid Antibodies Promote the Release of Neutrophil Extracellular Traps: a New Mechanism of Thrombosis in the Antiphospholipid Syndrome
Abstract Number: 2868

Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository Initial Analysis
Abstract Number: 17

Antiphospholipid Syndrome Following Infection: A Systematic Review of Case Reports
Abstract Number: L7

Antiphospholipid Syndrome without Anticoagulation: 0utcome of 50 Patients
Abstract Number: 5

Antiphospholipid-Associated Nephropathy Is a Risk for Developing Arterial Thromboses in Patients with Systemic Lupus Erythematosus
Abstract Number: 2108

Anxiety in Caregivers of Patients with Chronic Rheumatic Conditions
Abstract Number: 1102

Anxiety in Fibromyalgia Patients
Abstract Number: 2786

Aortitis: Outcomes from a Cohort of 196 Patients
Abstract Number: 984

Apolipoprotein B Is a Target of T and B Cell Responses in a Subgroup of Patients with Lyme Disease
Abstract Number: 1791

Applicability of the 2006 European League Against Rheumatism (EULAR) Criteria for the Classification of Henoch-Schönlein Purpura. an Analysis Based on 766 Patients with Cutaneous Vasculitis
Abstract Number: 1989

Application of an Experiential Learning Framework for Clinician Scholar Educator Training in a Rheumatology Fellowship
Abstract Number: 2714

Application of the 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis in Korean Patients with Raynaud Phenomenon
Abstract Number: 666

Approach to Discriminate Treatment Impact in Both Moderate and Severe SLE: The Atacicept Phase IIb Trial Design
Abstract Number: 2355

Apremilast, a Novel Phosphodiesterase 4 Inhibitor, and Methotrexate Independently Prevent Inflammation in Vivo and in Vitro
Abstract Number: 1561

Apremilast, an Oral Phosphodiesterase 4 Inhibitor, and the Impact of Baseline Weight and BMI on ACR20 and HAQ-DI Response: Pooled Results from 3 Phase 3, Randomized, Controlled Trials
Abstract Number: 955

Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Pharmacodynamic Results of a Phase 3, Randomized, Controlled Trial
Abstract Number: 1565

Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Improvement of Pain, Fatigue, and Disability in Patients with Psoriatic Arthritis: Results from 3 Phase 3, Randomized, Controlled Trials
Abstract Number: 1590

Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (104-Week) Improvements in Patients with Psoriatic Arthritis: Results from a Phase 3, Randomized, Controlled Trial
Abstract Number: 548

Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (52-Week) Improvement in Measures of Disease Activity in Patients with Psoriatic Arthritis: Results from 3 Phase 3, Randomized, Controlled Trials
Abstract Number: 1543

Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (52-Week) Improvement in the Signs and Symptoms of Psoriatic Arthritis in DMARD-Naive Patients: Results from a Phase 3, Randomized, Controlled Trial
Abstract Number: 1572

Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (52-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Results from a Phase 3, Randomized, Controlled Trial
Abstract Number: 1267

Are Anti-SRP Auto-Antibodies Specific for Myositis?
Abstract Number: 2523

Are Biologic Agents Effective on the Treatment of Secondary Amyloidosis: A Multicenter Report on Turkish Rheumatoid Arthritis and Ankylosing Spondylitis Patients
Abstract Number: 140

Are Entheses Ultrasound Findings Similar in Axial Spa Patients and in Athletes?
Abstract Number: 1365

ARE Erosions a Disappearing Feature in Rheumatoid Arthritis (RA)?Joint Damage in Patients with EARLY RA at 10 YEARS after Diagnosis
Abstract Number: 1789

Are EULAR/Printo/PRES Classification Criteria Appropriate for Classification of IgA Vasculitis in Adults?
Abstract Number: 2084

Are Genetic Markers Associated with Myocardial Infarction in Patients with Early Rheumatoid Arthritis?
Abstract Number: 1802

Are Outcomes after Total Knee Arthroplasty Worsening over Time? a Time-Trends Study of Activity Limitation and Pain Outcomes
Abstract Number: 2109

Are Patient Ratings of Providers and Health Plans Associated with Technical Quality of Care in SLE?
Abstract Number: 2519

Are Patients with Rheumatoid Arthritis Initiating a TNF Biologic Comparable to Patients Initiating a Non TNF?
Abstract Number: 1661

Are Repeat Renal Biopsies Important in Managing Lupus Nephritis Flares?
Abstract Number: 1368

Are Tender Joints Better Than Synovitis to Predict Structural Damage in Rheumatoid Arthritis?
Abstract Number: 1601

Are There Gender Specific Differences in Patient Characteristics at Initiation of Biologic Treatment in Ankylosing Spondylitis and Psoriatic Arthritis?
Abstract Number: 2055

Are There Immunological Abnormalities in Fibromyalgia Patients: Flow Cytometry Analysis
Abstract Number: 2557

Are We over-Treating with Nsaids Our Early Axial Spa Patients? Results from the DESIR Cohort
Abstract Number: 1153

Area of Residence and Socio-Economic Factors Significantly Affect Access to Biological Therapy for Rheumatoid Arthritis Patients in Romania
Abstract Number: 1771

Arterial Thrombotic Events in Systemic Vasculitis
Abstract Number: 441

Arthritis Associated Autoantibodies in Non-Rheumatoid Arthritis Patients with Mucosal Inflammation
Abstract Number: 59

Assessing Dietary Habits in a Large Cohort of Rheumatoid Arthritis and Psoriatic Arthritis Patients: Results of the Spanish Imid Consortium
Abstract Number: 2886

Assessing Rheumatology Fellows’ Teaching Skills Using the Objective Structured Teaching Exercise (OSTE)
Abstract Number: 1172

Assessing the Validity and Reliability of a Novel MRI Semi-Automated Algorithm for Quantifying Bone Loss in the Hand
Abstract Number: 2411

Assessing Treatment Durability of Infliximab in the Management of Psoriatic Arthritis and Rheumatoid Arthritis Patients in a Canadian Setting
Abstract Number: 1351

Assessment of ACR Endorsed Quality Indicators in Rheumatoid Arthritis Patients – a Quality Improvement Initiative
Abstract Number: 69

Assessment of Exercise Status in Routine Care Using Patient Reported Outcomes: Initiating Exercise Is Associated with Better Outcomes Than No Exercise
Abstract Number: 487

Assessment of Lipid Changes in Patients with Early Rheumatoid Arthritis Treated with Tofacitinib or Methotrexate over 24 Months
Abstract Number: 758

Assessment of mRNA Gene Expression Based on Forearm Skin Score in Systemic Sclerosis Patients
Abstract Number: 2637

Assessment of Plaque Thickness and Area in Patients with SLE As Measures of Atherosclerosis – Associations with Disease Activity
Abstract Number: 1246

Assessment of Protective Factors of Bone Mineral Density in a New Orleans Sarcoidosis Population
Abstract Number: 1396

Assessment of Pulmonary Function in Rheumatoid Arthritis Patients Attending Rheumatology Clinics in Nairobi,Kenya
Abstract Number: 2096

Assessment of RA Heterogeneity in Two Independent Cohorts of Patients
Abstract Number: 2592

Assessment of Spondyloarthritis International Society Endorsed Recommendations for Early Referral of Patients Suspected for Axial Spondyloarthritis
Abstract Number: 2490

Assessment of Structural Benefits of SC Abatacept Using MRI in Patients with RA Who Have Failed 1 or 2 TNFs and Correlated with Clinical Outcomes As Measured By DAS28(ESR)
Abstract Number: 1273

Assessment of the Effect of Rituximab in the Treatment of Interstitial Lung Disease associated with the Antisynthetase Syndrome
Abstract Number: 2064

Assessment of the Spanish Version of the American College Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia
Abstract Number: 2272

Assessment of Transition Readiness in Adolescents and Young Adults with Rheumatic and Other Chronic Health Conditions
Abstract Number: 2964

Association Analysis of Apolipoprotein B and Very Low-Density Lipoprotein with Hyperuricemia and Gout
Abstract Number: 211

Association Between Baseline External Knee Adduction and Flexion Moments during Gait and Medial Tibiofemoral Cartilage Thickness Loss over Two Years in Persons with Knee Osteoarthritis (OA)
Abstract Number: 1275

Association Between Cardiometabolic Disorders and Hand Osteoarthritis Severity: A Cross-Sectional and Longitudinal Study
Abstract Number: 1635

Association Between Carrying at Least One Apolipoprotein1 Variant Allele and Hypertension in Lupus Patients with Normal Renal Function
Abstract Number: 1438

Association Between Chronic Inflammatory Conditions and Anti Cyclic Citrullinated Peptide Antibodies in Patients with Early Rheumatoid Arthritis
Abstract Number: 2117

Association Between Depression and High Utilization of Emergency Department in Patients with Systemic Lupus Erythematosus from the Southeastern United States: The Goal Cohort
Abstract Number: 789

Association Between Histological Features and Clinical Features of Patients with Biopsy Positive Giant Cell Arteritis
Abstract Number: 225

Association Between Lean Mass and Hip Bone Mineral Density
Abstract Number: 806

Association of a Single Nucleotide Polymorphism (SNP) in IL-12B Region with Clinical Features and Peripheral T Cell Profiles of Patients with Takayasu Arteritis
Abstract Number: 2735

Association of a-Kinase Anchoring Protein-79 (AKAP79) to PKC Mediates Inhibition of IL2 Transcription and Erk Activation in T Cells
Abstract Number: 2684

Association of Adam33 Polymorphisms with Systemic Lupus Erythematosus
Abstract Number: 401

Association of Anti-Thyroid Autoantibodies with Fibromyalgia in Rheumatoid Arthritis
Abstract Number: 413

Association of Antinuclear Antibodies with Lung Disease, Malignancy and Joint Replacement in Rheumatoid Arthritis
Abstract Number: 2085

Association of Circulating Mirnas with Spinal Involvement in Patients with Axial Spondyloarthritis
Abstract Number: 864

Association of Coronary Artery Calcification with Brown and White Pericardial Adipose Tissue in SLE
Abstract Number: 1677

Association of Gastrointestinal Symptoms with Immunosuppressant Use in the Prospective Registry of Early Systemic Sclerosis Cohort
Abstract Number: 1651

Association of Glomerular Macrophage Phenotypes and Urine Soluble CD163 with Disease Activity in Human Lupus Nephritis
Abstract Number: 1175

Association of Hand MRI Findings with the Level of Plasma Cytokines in Patients with Newly Diagnosed Rheumatoid Arthritis
Abstract Number: 1788

Association of HLA-B*41 with Henoch-Schönlein Purpura in Spanish Individuals Irrespective of the HLA-DRB1 Status
Abstract Number: 306

Association of Kawasaki Disease with Tropospheric Winds in Central Chile: Is Wind-Borne Desert Dust a Risk Factor?
Abstract Number: 66

Association of Knee Osteoarthritis and Limitations in Physical Function in a Rural Chinese Population: The Wuchuan OA Study
Abstract Number: 86

Association of Leukocyte Immunoglobulin-like Receptor A3 (LILRA3) with Systemic Sclerosis
Abstract Number: 1278

Association of Low Birth Weight and Preterm Birth with the Incidence of Knee and Hip Arthroplasty for Osteoarthritis
Abstract Number: 1090

Association of Objectively Measured Physical Activity and Metabolic Syndrome Among Adults with Osteoarthritis in the United States
Abstract Number: 386

Association of Pharmacogenetic Markers with Treatment Response in Patients with Rheumatoid Arthritis
Abstract Number: 612

Association of Platelet Endothelial Cell Adhesion Molecule-1 and beta1 Integrin Gene Polymorphisms with Uveitis Development in Ankylosing Spondylitis
Abstract Number: 1140

Association of Polymorphisms on OPG, RANK and RANKL with ACPA Presence and Erosions: Results of a Meta-Analysis on 1570 Rheumatoid Arthritis Patients from 3 French Cohorts
Abstract Number: 2922

Association of Single Nucleotide Polymorphisms of PADI4 Gene with Susceptibility to Rheumatoid Arthritis-Related Lung Disease
Abstract Number: 2585

Association of Smoking with Acute Phase Reactants and Molecules Involved in Bone Formation in Patients with Ankylosing Spondylitis
Abstract Number: 2962

Association of the Toll-like Receptor 4 (TLR4) Gene with Gout
Abstract Number: 2088

Association of TNFAIP3 Gene Polymorphisms with the Risk for RA and Prediction of Therapy Outcome of TNFα-Blocker Treatment
Abstract Number: 87

Association of TRIM21 (RO52) Polymorphisms with Systemic Lupus Erythematosus in a Japanese Population
Abstract Number: 1336

Associations of Physical and Mental Factors with Outcome Expectations for Exercise in a Clinical Trial
Abstract Number: 2456

Associations of Toll-like Receptor (TLR)-4 Single Nucleotide Polymorphisms and Rheumatoid Arthritis Disease Progression
Abstract Number: 1440

Asymptomatic Carotid Plaques in RA Patients Are Associated with Increased HDL Function
Abstract Number: 829

Asymptomatic Deposit of Monosodium Urate Crystals Associates to a More Severe Coronary Calcification in Hyperuricemic Patients with Acute Coronary Syndrome
Abstract Number: 126

Asymptomatic Versus Symptomatic Ankle Joints in Rheumatoid Arthritis: A High Resolution B-Mode and Power Doppler Ultrasound Study
Abstract Number: 2762

Atrophy of Hippocampal Region in Chronic Progressive Neuro-Behçet’s Disease
Abstract Number: 2427

Attainment of Low Disease Activity Is Predictive of Maintenance of Disease Control upon Adalimumab Discontinuation for Two Years Following Combination Therapy in Japanese Patients with Early Rheumatoid Arthritis
Abstract Number: 2935

Attainment of Minimal Disease Activity Using Methotrexate in Psoriatic Arthritis
Abstract Number: 1732

Attenuation of Sclerodermatous Graft Versus Host Disease (sclGVHD) in IL4RA Receptor-Deficient Mice
Abstract Number: 2662

Attribution Protocol and Clinical Significance of Neuropsychiatric Manifestations in Childhood-Onset Systemic Lupus Erythematosus
Abstract Number: 1626

Autoantibodies Against High Mobility Group Box 1 (HMGB1) in Patients with SLE
Abstract Number: 2782

Autoantibodies from Single Circulating Plasmablasts React with Citrullinated Antigens and Porphyromonas Gingivalis in Rheumatoid Arthritis
Abstract Number: 320

Autoantibodies in Juvenile Systemic Sclerosis
Abstract Number: 2541

Autoantibodies in Pediatric Sjogren’s Patients
Abstract Number: 2985

Autoantibodies to 14-3-3η Are Novel Biomarkers Associated with Inflammation and Radiographic Progression in Ankylosing Spondylitis
Abstract Number: 3004

Autoantibody-Mediated Raynaud’s Phenomenon: Animal Model and Human Disease
Abstract Number: 703

Autoimmune Hepatitis in Systemic Lupus Erythematosus
Abstract Number: 2252

Autoimmune Thyroid Disease Is Associated with a Higher Frequency of Spinal Degenerative Disc Disease
Abstract Number: 1530

Autologous Tolerogenic Dendritic Cells for Rheumatoid and Inflammatory Arthritis
Abstract Number: 149

Automated Digital Analysis of Major Salivary Gland Ultrasound Images
Abstract Number: 2147

Automatically Extracted Quantitative Biomarkers for Assessing Connective Tissue Disease Using Nailfold Capillaroscopy
Abstract Number: 1008

Autophagy Activation Protects from Mitochondrial Dysfunction in Human Chondrocytes
Abstract Number: 611

Autophagy and Unfolded Protein Response: A Fine Balance That Can Influence the Pathogenesis of Ankylosing Spondylitis and Inflammatory Bowel Disease
Abstract Number: 2690

Autoregulatory Function of IL-10 Producing Pre-Naïve B Cells Is Defective in Systemic Lupus Erythematosus
Abstract Number: 1796

Autotaxin Is Highly Expressed in Systemic Sclerosis (SSc) Skin, Mediates Dermal Fibrosis Via IL-6, and Is a Target for SSc Therapy